FDA Clears First Commercially Available Blood Test to Evaluate for TBI, Concussion
Drug Topics
MARCH 7, 2023
The test is intended to complement the company’s TBI plasma test, which received FDA clearance in 2021.
Tue.Mar 07, 2023
201 
How one medical school became remarkably diverse — without considering race in admissions
STAT
MARCH 7, 2023
The diversity of medical school classes has barely budged in recent decades, even with the ability to consider an applicant’s race as one factor in admissions. Now, many medical school leaders fear a looming U.S. Supreme Court decision to restrict or ban race-conscious admissions policies could lead to precipitous declines, imperiling efforts to fight the nation’s stark racial and ethnic health disparities.
Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Cancer Risk Associated With UV Nail Dryers
Drug Topics
MARCH 7, 2023
The safety of gel manicures is under renewed scrutiny after a new study suggested they can cause DNA damage
HRG awards Nature's Truth No. 1 in Independent Pharmacy two years running
Drug Store News
MARCH 7, 2023
The brand also earned accolades across several subcategories, including letter vitamins, herbals and botanicals, specialty supplements and mineral supplements.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Show Them The Money
Drug Topics
MARCH 7, 2023
The role of the pharmacy technician has evolved over the past 45 years—but pay hasn’t caught up
Congress Probes PBM Link to Higher Drug Prices
PharmExec
MARCH 7, 2023
Latest investigation signals more scrutiny of pharmacy benefit managers and their role in treatment cost and coverage.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
NACDS commends intro of PBM reform legislation in Florida
Drug Store News
MARCH 7, 2023
Steve Anderson, president and CEO of the National Association of Chain Drug Stores, said HB 1509/SB 1550 will finally hold PBMs accountable.
CNM-Au8 could address vision problems in multiple sclerosis
Pharmaceutical Technology
MARCH 7, 2023
Clene has presented updated trial results for its Visionary MS Phase II clinical trial for its lead pipeline candidate, CNM-Au8. The trial is investigating CNM-Au8 as a treatment for patients with relapsing forms of multiple sclerosis (MS) with chronic optic neuropathy. The agent has a first-in-class mechanism of action within the MS portfolio, as it is a first drinkable treatment based on a nanocrystalline gold suspension that has reached late-stage development for MS.
With CRISPR cures on horizon, sickle cell patients ask hard questions about who can access them
STAT
MARCH 7, 2023
LONDON — Victoria Gray had come to Nashville, Tenn., from her home in Mississippi for what was supposed to be a routine checkup. But when a pain crisis struck — an agonizing emergency of sickle cell disease in which Gray’s misshapen red blood cells caught in her blood vessels — the visit became a days-long hospital stay. It was in the midst of this attack that her doctor told her about a clinical trial for a new kind of treatment, one where CRISPR would be used to alt
Why do I feel nauseous after working out?
The Checkup by Singlecare
MARCH 7, 2023
You’re midway through your run, but then you start to feel queasy. It’s unpleasant, sure. But you may be wondering, “Why do I feel nauseous after working out?” The good news is that most cases of post-workout nausea are not serious. During exercise, the body sends blood to major muscle groups, which reduces blood flow to abdominal organs. This can lead to nausea.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
How can states keep people insured after Medicaid protections lapse? Connecticut has an idea
STAT
MARCH 7, 2023
WASHINGTON — It’s hard to shop for health insurance. It’s harder still when there’s few options to help. Some Americans who can’t rely on a federal program or their employers’ HR department turn to brokers who are trained to help them navigate the complex web of deductibles, formularies, and subsidies. But in 2021 in Hartford, Bridgeport, and New Haven, Connecticut — as in many poorer areas in the U.S.
Topco to host Product Solutions Summit
Drug Store News
MARCH 7, 2023
The company is seeking suppliers to help expand its supplier partnership portfolio and sourcing capabilities to provide member-owners with a more expansive assortment of products and offerings.
STAT+: Q&A: Califf on obesity drugs, advisory panels, and how threats hurt recruitment at FDA
STAT
MARCH 7, 2023
BOSTON — FDA Commissioner Robert Califf said on Monday that it “bothers” him that Novo Nordisk, which makes an obesity medication, funded the development of obesity coursework for medical schools. But he also said he saw it as an example of a drug company filling the void left by health systems that aren’t teaching doctors and trainees how to use new medicines.
St. Moriz debuts self-tanning set at Ulta
Drug Store News
MARCH 7, 2023
The set contains the brand's Tan Boosting Face Drops, Instant Self-Tanning Mousse and a Velvet Mitt for easy application to help users build, extend and enjoy their tans.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT+: Best Buy-Atrium deal offers glimpse of tech’s future in home health
STAT
MARCH 7, 2023
Best Buy isn’t the first name that comes to mind when people think of health care. But a new partnership between the electronics retailer and Atrium Health, part of the nonprofit health system Advocate Health, is a sign of how big tech and retail companies are getting in on the booming hospital-at-home market. Best Buy first dove into the health care space with its 2021 acquisition of Current Health, a remote patient monitoring platform that major hospital systems across the country rely
Providers join insurers in calls for changes to controversial Medicare Advantage pay rule
Fierce Healthcare
MARCH 7, 2023
Providers join insurers in calls for changes to controversial Medicare Advantage pay rule rking Tue, 03/07/2023 - 14:23
STAT+: Controversial drug for premature birth is withdrawn by manufacturer after battle with FDA
STAT
MARCH 7, 2023
After months of anticipation, the manufacturer of a controversial drug for premature births has agreed to withdraw its treatment, capping an unusual battle with the U.S. Food and Drug Administration over its authority to have medicines removed from the market. The drug in question, called Makena, was approved more than a decade ago and quickly generated a firestorm over its cost.
Mucinex, WNBA MVP Lisa Leslie team up to help consumers with cold and flu symptoms
Drug Store News
MARCH 7, 2023
Through the campaign, which runs March 1–26, consumers can send their friends and family a pick-me-up video—personalized through AI—featuring the WNBA star.
A Theranos that works, Best Buy’s home health play, & a chat with B Capital’s Robert Mittendorf
STAT
MARCH 7, 2023
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.
Walgreens-backed VillageMD picks up Starling Physicians to broaden primary care footprint in the Northeast
Fierce Healthcare
MARCH 7, 2023
Walgreens-backed VillageMD picks up Starling Physicians to broaden primary care footprint in the Northeast hlandi Tue, 03/07/2023 - 09:58
Giant partners with Keep Pennsylvania Beautiful to offer Healing the Planet grant program
Drug Store News
MARCH 7, 2023
Through the joint partnership, $300,000 in grants will be awarded to projects focused on preventing, reducing and recovering food waste.
Rivaroxaban Plus Aspirin Reduces Acute Limb Ischemia After Lower Extremity Revascularization in PAD
Drug Topics
MARCH 7, 2023
Results of an analysis of the VOYAGER PAD clinical trial were presented at ACC.23.
Grove Collaborative, Drew Barrymore launch limited-edition collection
Drug Store News
MARCH 7, 2023
The Fresh Horizons limited edition collection consists of sustainable, bright and colorful home care essentials, the company said.
Sarissa's overhaul of Amarin's board is complete with resignation of 7 holdover members
Fierce Pharma
MARCH 7, 2023
Sarissa's overhaul of Amarin's board is complete with resignation of 7 holdover members kdunleavy Tue, 03/07/2023 - 09:41
One Medical CEO rebuts Amazon data privacy concerns
Pharmaceutical Technology
MARCH 7, 2023
The recently closed Amazon-One Medical acquisition focuses on a “longitudinal relationship” with individual members and has nothing to do with patient data, said One Medical’s CEO Amir Dan Rubin, amidst data privacy concerns surrounding the deal, at a recent panel. On 6 March, at the Wall Street Journal (WSJ) Health Forum, Rubin said the deal should not invite any data privacy concerns given its structure.
Kiss’ imPRESS, LoveShackFancy bring springtime florals to at-home manicures
Drug Store News
MARCH 7, 2023
The LoveShackFancy x imPRESS Press-On Manicure collection comes in soft hues and vintage-inspired details and prints.
#FierceMadness: Help us select the healthcare leaders for this year's face-off
Fierce Healthcare
MARCH 7, 2023
#FierceMadness: Help us select the healthcare leaders for this year's face-off pminemyer Tue, 03/07/2023 - 13:26
AbbVie CEO Gonzalez scored $26M in 2022 pay as cash cow Humira neared patent cliff
Fierce Pharma
MARCH 7, 2023
AbbVie CEO Gonzalez scored $26M in 2022 pay as cash cow Humira neared patent cliff aliu Tue, 03/07/2023 - 10:54
Dollar General reformulates, rebrands private label offering
Drug Store News
MARCH 7, 2023
Dollar General has reformulated and rebranded its dog and cat food line, Nature’s Menu.
Sanofi's site modernization spree rolls on with plan to shift 2,000 staffers to new flexible workspace in New Jersey
Fierce Pharma
MARCH 7, 2023
Sanofi's site modernization spree rolls on with plan to shift 2,000 staffers to new flexible workspace in New Jersey fkansteiner Tue, 03/07/2023 - 10:50
3 keys to good storytelling in pharma
PharmaVoice
MARCH 7, 2023
The CEO of Complement Therapeutics shares simple storytelling tactics lead to maximum impact.
Pistoia Alliance launches Pharma Innovation Council
European Pharmaceutical Review
MARCH 7, 2023
The Pistoia Alliance has launched its Pharma Innovation Council. It will be made up of 13 leaders from large global pharmaceutical companies. The Council will explore common challenges develop ideas for new pre-competitive projects aligned with the Alliance’s strategic themes, including Emerging Sciences and Technology and Improving the Efficiency and Effectiveness of R&D.
FDA delays BioMarin's gene therapy approval decision by 3 months
Fierce Pharma
MARCH 7, 2023
FDA delays BioMarin's gene therapy approval decision by 3 months zbecker Tue, 03/07/2023 - 10:41
BioMarin receives FDA update for gene therapy for adults with severe haemophilia A
Pharmafile
MARCH 7, 2023
Global biotechnology company BioMarin Pharmaceutical has announced that it’s received an update from the FDA, detailing the extension of their review of the company’s Biologics License Application (BLA) for Roctavian™. Roctavian™ (valoctocogene roxaparvovec) is a gene therapy for adults with severe haemophilia A, an X-linked genetic disorder caused by missing or defective Factor VIII ‒ a clotting protein.
Let's personalize your content